BTIG Is 'Generally Skeptical' On Kite Pharma Expectations

By: via Benzinga
BTIG has started coverage of Kite Pharma Inc (NASDAQ: KITE) with a Neutral rating, as it is skeptical over current investor expectations ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.